Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

GPE bolsters West End estate with £18m purchase

(Sharecast News) - Real estate group Great Portland Estates has bolstered its portfolio of fully managed buildings within the West End with the £18m acquisition of The Gable, WC1 from the City of London Corporation. The Gable, located within walking distance from Tottenham Court Road station, is a 44,000 square foot building currently partially let at an annual rent of £1.5m, generating a net yield of 6.4%.

However, GPE plans to "substantially refurbish" the site to offer customer amenities, private terracing and a re-configured retail space, with works expected to start in the third quarter of 2026.

Under the company's plans, the development yield is expected to rise to 6.9%, delivering an ungeared internal rate of return of 11%+.

Together with the recently acquired Courtyard Building and Whittington House, and existing holdings at 31/34 Alfred Place, The Gable acquisition will create a 220,000 sq ft cluster of fully managed and headquarter space in WC1.

"The Gable is a strong addition to this central London Flex cluster and reflects our commitment to expanding the Fully Managed portfolio to over 1 million sq ft by 2030," said chief executive Toby Courtauld.

"Building on a successful summer of launches, we are confident in our strategy and ability to meet customer demand. Once refurbished."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.